Deutsch English Français

Contact

EP2681560

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2681560

EP2681560 - METHOD FOR DETECTING PARVOVIRUS ANTIGEN [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 06.01.2017 Database last updated on 17.07.2024
Most recent event Tooltip	06.01.2017	Application deemed to be withdrawn	published on 08.02.2017 [2017/06]
Applicant(s)	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
	[2014/38]
Former [2014/02]	For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH
	For all designated states Universitaet Regensburg Universitaetsstrasse 31 93040 Regensburg / DE
Inventor(s)	01 / BROEKER, Michael Novartis Vaccines and Diagnostics GmbH Emil-Von-Behring-Strasse 76 35041 Marburg / DE
	02 / MODROW, Susanne Universitaet Regensburg Universitaetsstrasse 31 93040 Regensburg / DE
	03 / BREDL, Simon Universitaet Regensburg Universitaetsstrasse 31 93040 Regensburg / DE
	[N/P]
Former [2014/02]	01 / BROEKER, Michael Novartis Vaccines and Diagnostics GmbH Emil-Von-Behring-Strasse 76 35041 Marburg / DE
	02 / MODROW, Susanne Universitaet Regensburg Universitaetsstrasse 31 93040 Regensburg / DE
	03 / BREDEL, Simon Universitaet Regensburg Universitaetsstrasse 31 93040 Regensburg / DE
Representative(s)	Finnie, Nicholas James, et al Novartis Pharma AG Patent Department 4002 Basel / CH
	[N/P]
Former [2014/02]	Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
Application number, filing date	12709383.9	02.03.2012
	WO2012IB51007
Priority number, date	US201161464469P	03.03.2011 Original published format: US 201161464469 P
	[2014/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012117382
	Date:	07.09.2012
	Language:	EN
	[2012/36]
	Type:	A1 Application with search report
	No.:	EP2681560
	Date:	08.01.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.09.2012 takes the place of the publication of the European patent application.
	[2014/02]
Search report(s)	International search report - published on:	EP	07.09.2012
Classification	IPC:	G01N33/569	[2014/02]
	CPC:	G01N33/56983 (EP,US); G01N2333/015 (EP,US); G01N2469/10 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/02]
Title	German:	VERFAHREN ZUM NACHWEIS VON PARVOVIRUS-ANTIGEN	[2016/15]
	English:	METHOD FOR DETECTING PARVOVIRUS ANTIGEN	[2014/02]
	French:	METHODE DE DETECTION D'ANTIGENE DE PARVOVIRUS	[2016/15]
	Former [2014/02]	VERFAHREN FÜR DEN NACHWEIS VON PARVOVIRUS-ANTIGEN
	Former [2014/02]	PROCÉDÉ DE DÉTECTION D'UN ANTIGÈNE PARVOVIRUS
Entry into regional phase	04.10.2013	National basic fee paid
	04.10.2013	Designation fee(s) paid
	04.10.2013	Examination fee paid
Examination procedure	08.10.2012	Request for preliminary examination filed International Preliminary Examining Authority: EP
	04.10.2013	Examination requested [2014/02]
	04.04.2014	Amendment by applicant (claims and/or description)
	04.04.2016	Communication of intention to grant the patent
	17.08.2016	Application deemed to be withdrawn, date of legal effect [2017/06]
	21.09.2016	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2017/06]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.04.2016
Fees paid	Renewal fee
	13.03.2014	Renewal fee patent year 03
	10.03.2015	Renewal fee patent year 04
	10.03.2016	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO9609391 (WOLF HANS [DE], et al) [Y] 12 * abstract * * claims 1-16 *;
		[XY]WO2007140011 (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1-4,9-12 * abstract * * page 11, line 31 - page 12, line 5 * * page 31, lines 9-27 * * page 38 * * claims 1,15,16,43,52,53,65 * [Y] 5-8;
		[XY]WO2008072216 (BIOTRIN INTELLECTUAL PTY LTD [IE], et al) [X] 13-15 * abstract * * page 2, line 14 - page 5, line 14 * * page 8, line 19 - page 9, line 8 * * claims 1-13 * [Y] 5-8;
		[XY]WO2009109604 (SCHMIDT-LUCKE CAROLINE [DE], et al) [X] 13-15 * abstract * * page 2 - page 3, line 28 * * page 5, line 27 - page 6, line 32 * * page 7, line 13 - page 8, line 3 * * claims 1-15 * [Y] 5-8;
		[XY] - WONG S. ET AL., "Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication", J. VIROL., (200803), vol. 82, no. 5, pages 2470 - 2476, XP055026386 [X] 1,2 * abstract * * page 2471 * [Y] 5-8,12 DOI: http://dx.doi.org/10.1128/JVI.02247-07
		[A] - GIGLER A. ET AL., "Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins", J. VIROL., (199903), vol. 73, no. 3, pages 1974 - 1979, XP055026464 [A] 1-15 * abstract * * page 1975 *
		[A] - VON POBLOTZKI A. ET AL., "Antibodies to parvovirus B19 NS-1 protein in infected individuals", J. GEN. VIROL., (199503), vol. 76, no. 3, pages 519 - 527, XP002005738 [A] 1-15 * abstract *
	by applicant	WO2009109604
		- MODROW, DER MIKROBIOLOGIE, (2007), vol. 17, pages 6 - 15
		- MODROW ET AL., Medizinische Virologie - Grundlagen Diagnostik, Prävention und Therapie viraler Erkrankungen, THIEME, (2010), pages 611 - 623
		- YOUNG; BROWN, NENGL JMED., (2004), vol. 350, no. 6, pages 586 - 97
		- "Human and Primate Parvovirus Infections and Associated Disease", KERR; MODROW ET AL., Parvoviruses, ARNOLD PUBLISHERS, (2006), pages 385 - 416
		- COTMORE ET AL., J. VIROL., (1986), vol. 60, no. 2, pages 548 - 57
		- BLUNDELL ET AL., VIROLOGY, (1987), vol. 157, no. 2, pages 534 - 8
		- DOERIG ET AL., J. VIROL., (1990), vol. 64, no. 1, pages 387 - 96
		- ST AMAND ET AL., VIROLOGY, (1991), vol. 183, no. 1, pages 133 - 42
		- LUO; ASTELL, VIROLOGY, (1993), vol. 195, no. 2, pages 448 - 55
		- OZAWA, TANPAKUSHITSU KAKUSAN KOSO, (1992), vol. 37, no. 14, pages 2348 - 54
		- GAREUS ET AL., J. VIROL., (1998), vol. 72, pages 509 - 516
		- MOFFAT ET AL., J. VIROL., (1998), vol. 72, pages 3018 - 3028
		- RAAB ET AL., J. GEN. VIROL., (2002), vol. 82, pages 1473 - 1480
		- HSU ET AL., SCAND J INFECT DIS., (2004), vol. 36, pages 570 - 577
		- LEHMANN ET AL., AUTOIMMUNE REV., (2003), vol. 2, no. 4, pages 218 - 23
		- LEHMAN; MODROW, CURRENT RHEUMATOLOGY REVIEWS, (2006), vol. 2, pages 159 - 175
		- MODROW; GÄRTNER, DEUTSCHES ÄRTZEBLATT, (2006), vol. 103, no. 43, pages A2869 - 2876
		- TOLFVENSTAM; BROLINDEN, SEMIN FETAL NEONATAL MED., (2009), vol. 14, pages 218 - 21
		- LIEFELDT ET AL., J. MED. VIROL., (2005), vol. 75, no. 1, pages 161 - 9
		- BLÜMEL ET AL., J. VIROL., (2005), vol. 79, no. 22, pages 14197 - 206
		- HEMAUER ET AL., J. GEN. VIROL., (1999), vol. 80, pages 627 - 30
		- WONG ET AL., J. VIROL., (2008), vol. 82, no. 5, pages 2470 - 6
		- GIGLER ET AL., J. VIROL., (1999), vol. 73, no. 3, pages 1974 - 9
		- ROS ET AL., VIROLOGY, (2006), vol. 345, pages 137 - 147
		- BOSCHETTI ET AL., TRANSFUSION, (2004), vol. 44, no. 7, pages 1079 - 86
		- YUNOKI ET AL., VOX SANG, (2003), vol. 84, no. 3, pages 164 - 9
		- ROSENFELD ET AL., J CLIN INVEST., (1992), vol. 89, no. 6, pages 2023 - 9
		- QIU ET AL., J. VIROLOGY, (2007), vol. 81, no. 21, pages 12080 - 12085
		- TAKAHASHI ET AL., J. INFECT. DIS., (1989), vol. 160, no. 3, pages 548 - 9
		- TAKAHASHI ET AL., ARCH. VIROL., (1993), vol. 131, no. 1-2, pages 201 - 8
		- MIYAGAWA ET AL., J. VIROL. METHODS., (1999), vol. 83, no. 1-2, pages 45 - 54
		- MUNSHI ET AL., J. VIROL., (1993), vol. 67, no. 1, pages 562 - 6
		- SHIMOMURA ET AL., BLOOD, (1992), vol. 79, no. 1, pages 18 - 24
		- MORITA ET AL., J. VIROL., (2001), vol. 75, no. 16, pages 7555 - 63
		- WONG; BROWN, J. CLIN. VIROL., (2006), vol. 35, no. 4, pages 407 - 13
		- OZAWA ET AL., SCIENCE, (1986), vol. 233, no. 4766, pages 883 - 6
		- OZAWA ET AL., BLOOD, (1987), vol. 70, no. 2, pages 384 - 91
		- SRIVASTAVA; LU, J. VIROL., (1988), vol. 62, no. 8, pages 3059 - 63
		- SCHWARZ ET AL., J. VIROL., (1992), vol. 66, no. 2, pages 1273 - 6
		- SRIVASTAVA ET AL., VIROLOGY, (1992), vol. 189, no. 2, pages 456 - 61
		- BROWN ET AL., J. GEN. VIROL., (1991), vol. 72, pages 741 - 5
		- YAEGASHI ET AL., J. VIROL., (1989), vol. 63, no. 6, pages 2422 - 6
		- WONG ET AL., J. VIROL., (2007), vol. 82, no. 5, pages 2470 - 6
		- FREYSSINIER ET AL., BR. J. HAEMATOL., (1999), vol. 106, no. 4, pages 912 - 22
		- GIARRATANA ET AL., NAT. BIOTECHNOL., (2005), vol. 23, no. 1, pages 69 - 74
		- FILIPPONE ET AL., PLOS ONE, (2010), vol. 5, no. 3, page E9496
		- Methods In Enzymology, ACADEMIC PRESS INC
		- Handbook ofExperimental Immunology, BLACKWELL SCIENTIFIC PUBLICATIONS, (1986), vol. I-IV
		- Current Protocols in Molecular Biology, (1987), vol. 30
		- SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489
		- BROWN ET AL., SCIENCE, (1993), vol. 262, no. 5130, pages 114 - 7

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p